GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Trial Data] nausea rates in the combination arm vs sema alone — 27 comments in the full submission. View in context.
779
c/cagrilintide·submitted 18 days ago by u/egfr_watcher

[Trial Data] nausea rates in the combination arm vs sema alone

Trial Databranch of 7 comments

Right, the amylin question again, but with numbers this time. I have 11 data points over 10 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign. The thing I would flag for anyone new: the effect I am describing…

Read the full submission and all 27 comments →

This branch

7 comments, started 18 days ago
u/forest_plot_fionastats12 points·18 days ago

CagriSema ratios in trials are fixed, do not extrapolate self-mixing

replysharereportpermalink
u/egfr_watcherOP9 points·17 days ago

The research community is small on cagrilintide. Forum lore changes faster than data.

replysharereportpermalink
u/sten_rautio13 points·17 days ago

Respectfully this is a sample of one presented as a finding.

replysharereportpermalink
u/ines_ekstrom0 points·17 days ago

long-acting amylin is CagriSema, different satiety profile

replysharereportpermalink
u/zeynep_ndiaye6 points·17 days ago

Strongly agree. REDEFINE is phase 7, not final.

replysharereportpermalink
u/noor_vermeulen-28 points·17 days ago

Yeah, amylin is doing different work than GLP-1.

replysharereportpermalink
load more comments (1) →

← back to the whole thread

About c/cagrilintide

Amylin analog pharmacology and the CagriSema combination: why amylin and GLP-1 co-agonism produces a different satiety profile, the REDEFINE readouts, and the very limited pool of people handling cagrilintide as research material.

19kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/cagrilintide rules
  1. Amylin is not a GLP-1. Posts conflating them get corrected.
  2. CagriSema ratios in trials are fixed-dose. Do not extrapolate to self-mixing.
  3. Not approved anywhere. Keep posts descriptive, not instructional.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.